Answers are grounded in this paper and cite their sources.
PRACTICE POINTS• Adalimumab is an effective treatment for patients with hidradenitis suppurativa.• There is risk for opportunistic infections with adalimumab, and patients should be monitored closely.
No takes yet. Share an insight, caveat, or question.
Aaron S. Farberg (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: